Clinical Trials Using PEG-Proline-Interferon Alfa-2b

Clinical trials are research studies that involve people. The clinical trials on this list are studying PEG-Proline-Interferon Alfa-2b. All trials on the list are supported by NCI.

NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.

Trial 1 of 1
  • P1101 in Treating Patients with Myelofibrosis

    This pilot phase II trial studies P1101 (polyethyleneglycol [PEG]-proline-interferon alpha-2b) in treating patients with myelofibrosis. PEG-proline-interferon alpha-2b is a substance that can improve the body’s natural response and may slow the growth of myelofibrosis.
    Location: Mayo Clinic in Arizona, Scottsdale, Arizona